Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction (Q80834073)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

A Domínguez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

M Oviedo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

G Carmona

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

J Batalla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

M Bruguera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

L Salleras

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A Plasència

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

14 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1737-1741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

Clinical course and consequences of hepatitis A infection

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Protection against hepatitis A by an inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Effectiveness of a mass hepatitis A vaccination program in preadolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Changing prevalence, clinical features, and outcome of acute hepatitis in Spain (1982-2003).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Incidence of hepatitis A in the United States in the era of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Incidence of hepatitis A in Israel following universal immunization of toddlers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Estimated incidence of hepatitis A virus infection in Catalonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Six years' follow-up after hepatitis A vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Hepatitis A booster vaccination: is there a need?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Hepatitis A vaccination options for Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Hepatitis A in the era of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

The changing picture of hepatitis A in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Control of hepatitis A through routine vaccination of children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Adult infection with hepatitis A despite declining endemicity; in favor of adult vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

Hepatitis A vaccine: time for universal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.048

10.1016/J.VACCINE.2008.01.048

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18325642%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference